Research Topics
| D J DiekemaSummaryAffiliation: University of Iowa Country: USA Publications
| Collaborators
|
Detail Information
Publications
The changing epidemiology of healthcare-associated candidemia over three decadesDaniel Diekema
Division of Infectious Diseases, Department of Medicine, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA
Diagn Microbiol Infect Dis 73:45-8. 2012..glabrata (15% had FLU MICs >32 µg/mL). The epidemiology of HAC is changing at our hospital, with continued emergence of C. glabrata, fewer cases among oncology patients, and lower in-hospital and 30-day mortality...
Activities of available and investigational antifungal agents against rhodotorula speciesD J Diekema
Department of Internal Medicine, College of Public Health, University of Iowa, Iowa City, IA 52242, USA
J Clin Microbiol 43:476-8. 2005..12 microg/ml) are both active in vitro, and the new and investigational triazoles all have some in vitro activity, with ravuconazole being the most active (MIC(50), 0.25 microg/ml)...
Current practice in Staphylococcus aureus screening and decolonizationDaniel Diekema
Division of Infectious Diseases, Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA
Infect Control Hosp Epidemiol 32:1042-4. 2011..aureus. However, specific screening and decolonization practices are highly variable, are focused almost exclusively on methicillin-resistant S. aureus, and do not include testing for mupirocin or chlorhexidine resistance...
Rapid detection of antimicrobial-resistant organism carriage: an unmet clinical needDaniel J Diekema
Department of Internal Medicine, Division of Medical Microbiology, C 606 GH, 200 Hawkins Dr, Iowa City, IA 52242, USA
J Clin Microbiol 42:2879-83. 2004
Age-related trends in pathogen frequency and antimicrobial susceptibility of bloodstream isolates in North America: SENTRY Antimicrobial Surveillance Program, 1997-2000D J Diekema
Department of Pathology, Medical Microbiology Division, C606 GH, University of Iowa College of Medicine, 200 Hawkins Drive, Iowa City, IA 52242, USA
Int J Antimicrob Agents 20:412-8. 2002..This information should be helpful for clinicians as they consider empirical antimicrobial therapy for patients with suspected BSI across the age continuum...
Accuracy and appropriateness of antimicrobial susceptibility test reporting for bacteria isolated from blood culturesDaniel J Diekema
Division of Infectious Diseases, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa 52246, USA
J Clin Microbiol 42:2258-60. 2004..Further study is necessary to determine the impact of testing errors and suboptimal reporting of results on the management of bloodstream infection...
Evaluation of Etest and disk diffusion methods compared with broth microdilution antifungal susceptibility testing of clinical isolates of Candida spp. against posaconazoleDaniel J Diekema
Department of Pathology, Roy J and Lucille A Carver College of Medicine and College of Public Health, University of Iowa, Iowa City, IA 52242, USA
J Clin Microbiol 45:1974-7. 2007..These agar-based methods hold promise as simple and reliable methods for determination of the posaconzole susceptibilities of Candida spp...
Look before you leap: active surveillance for multidrug-resistant organismsDaniel J Diekema
University of Iowa Healthcare, Iowa City, IA, USA
Clin Infect Dis 44:1101-7. 2007....
Antimicrobial resistance trends and outbreak frequency in United States hospitalsDaniel J Diekema
Iowa City Veterans Affairs Medical Center, Dept of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA
Clin Infect Dis 38:78-85. 2004..The most common resistant pathogen in US hospitals is ORSA, which accounts for many recognized outbreaks and is increasing in frequency in most facilities. Current practices to prevent and control antimicrobial resistance are inadequate...
Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungiD J Diekema
Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, IA 52242, USA
J Clin Microbiol 41:3623-6. 2003..5 microg/ml. The new triazoles and caspofungin have excellent in vitro activity against a very large collection of recent clinical isolates of Aspergillus spp., and some in vitro activity against selected other filamentous fungi...
Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococciDaniel J Diekema
Department of Internal Medicine, University of Iowa Colleges of Medicine and Public Health, Iowa City, Iowa 52242, USA
J Clin Microbiol 41:2659-61. 2003..Erm methylase (ermA and ermB) was the most common resistance mechanism detected, present in 12 of 20 macrolide-resistant GBS...
Comparison of activities of broad-spectrum beta-lactam compounds against 1,128 gram-positive cocci recently isolated in cancer treatment centersD J Diekema
Department of Pathology, University of Iowa College of Medicine, Iowa City 52242, USA
Antimicrob Agents Chemother 43:940-3. 1999....
Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms studyD J Diekema
Division of Medical Microbiology, Department of Pathology, University of Iowa College of Medicine, Iowa City 52242, USA
J Clin Microbiol 40:1298-302. 2002..However, C. glabrata has emerged as an important and potentially antifungal resistant cause of candidemia, particularly among the elderly...
Oxazolidinone antibioticsD J Diekema
Division of Infectious Diseases, Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, Iowa 52242, USA
Lancet 358:1975-82. 2001..New agents with greater potency and new spectra of activity could arise from further modification of the oxazolidinone nucleus...
Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniaeD J Diekema
University of Iowa College of Medicine, Iowa City, Iowa 52242, USA
Emerg Infect Dis 6:552-6. 2000..S. medical centers, we obtained data on outpatient antimicrobial-drug use for the regions surrounding 23 of these centers. We found an association between decreased penicillin susceptibility and use of beta-lactam antimicrobial drugs...
Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997D J Diekema
Department of Pathology, University of Iowa College of Medicine, Iowa City 52242, USA
Clin Infect Dis 29:595-607. 1999..coli and Klebsiella species from Latin America. Further investigation of the reasons for regional differences in resistance patterns is needed, as is ongoing surveillance to detect resistance trends and to guide antimicrobial use...
In vitro activities of BMS-207147 against over 600 contemporary clinical bloodstream isolates of Candida species from the SENTRY Antimicrobial Surveillance Program in North America and Latin AmericaD J Diekema
Medical Microbiology Division, Department of Pathology, University of Iowa College of Medicine, Iowa City, Iowa 52242, USA
Antimicrob Agents Chemother 43:2236-9. 1999..that were dose-dependently fluconazole susceptible and against those that were fluconazole resistant...
Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant Staphylococcus aureus bloodstream isolates from SENTRY Antimicrobial Resistance Surveillance Centers worldwide, 1998D J Diekema
Department of Pathology, University of Iowa College of Medicine, Iowa City 52246, USA
Microb Drug Resist 6:213-21. 2000..aureus bloodstream isolates worldwide. Although many MDR-MRSA strains group geographically, a few closely related epidemic strains have wide regional and even global range...
Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin AmericaD J Diekema
Division of Medical Microbiology, Department of Pathology, University of Iowa College of Medicine, Iowa City, Iowa 52242, USA
Clin Microbiol Infect 7:152-7. 2001..To investigate antimicrobial resistance in viridans group streptococci (VGS) among patients with and without the diagnosis of cancer in the USA, Canada and Latin America...
Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial SurveillancD J Diekema
Medical Microbiology Division, Department of Pathology, University of Iowa College of Medicine, Iowa City, Iowa 52242, USA
Clin Infect Dis 32:S114-32. 2001..Given the increasing multidrug resistance among staphylococci and the possible emergence of vancomycin-resistant strains, global strategies are needed to control emergence and spread of multiply resistant staphylococci...
A global evaluation of voriconazole activity tested against recent clinical isolates of Candida sppDaniel J Diekema
Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA
Diagn Microbiol Infect Dis 63:233-6. 2009..008/0.25 microg/mL; 98% susceptible). In comparison to 5866 Candida spp. isolates collected during global surveillance from 1997 to 2001, there were no changes in voriconazole mean MIC or MIC distribution...
Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants GroupD J Diekema
Department of Pathology, University of Iowa College of Medicine, Iowa City 52242, USA
Int J Antimicrob Agents 13:257-71. 2000..Ongoing surveillance remains essential, and will enhance efforts to limit the scope of this worldwide problem...
Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005M A Pfaller
Department of Pathology, Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242, USA
J Clin Microbiol 46:842-9. 2008..parapsilosis to fluconazole and voriconazole may vary by geographic region and clinical service...
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial survM A Pfaller
Department of Pathology, Iowa City, Iowa 52242, USA
J Clin Microbiol 39:3254-9. 2001....
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testingM A Pfaller
Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA
J Clin Microbiol 47:117-23. 2009..These organisms may pose a future threat to optimal antifungal therapy and emphasize the importance of prompt and accurate species identification...
In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agentsM A Pfaller
Department of Pathology, University of Iowa College of Medicine and College of Public Health, Iowa City, IA, USA
Diagn Microbiol Infect Dis 48:101-5. 2004..Ravuconazole is clearly an "extended-spectrum" triazole with potent in vitro activity against these rare and potentially "emerging" opportunistic pathogens...
In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance programM A Pfaller
Department of Pathology, University of Iowa College of Medicine, Iowa City, IA, USA
Diagn Microbiol Infect Dis 48:201-5. 2004..and C. neoformans. These results provide further evidence for the increased spectrum and potency of the new triazoles against a large and geographically diverse collection of opportunistic fungal pathogens...
Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazoleM A Pfaller
Department of Pathology Medicine, Roy J and Lucille A Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242, USA
J Clin Microbiol 41:1875-80. 2003..The agar-based methods performed well in identifying isolates with resistance to fluconazole and decreased susceptibility to voriconazole...
Comparison of the Vitek Gram-Positive Susceptibility 106 card and the MRSA-screen latex agglutination test for determining oxacillin resistance in clinical bloodstream isolates of Staphylococcus aureusT Yamazumi
Medical Microbiology Division, Department of Pathology, University of Iowa College of Medicine, Iowa City, Iowa 52242, USA
J Clin Microbiol 39:53-6. 2001..Both methods were sensitive and specific for detecting staphylococcal oxacillin resistance in the clinical microbiology laboratory...
Comparison of results of voriconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance programM A Pfaller
Department of Pathology, Roy J and Lucille A Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA
J Clin Microbiol 43:5208-13. 2005....
Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. Tested by clinical and laboratory standards institute-recommended broth microdilution methodsM A Pfaller
Medical Microbiology Division, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA
J Clin Microbiol 45:70-5. 2007..Clinical laboratories performing antifungal susceptibility testing of fluconazole against Candida spp. can reliably use these results as surrogate markers until commercial FDA-approved voriconazole susceptibility tests become available...
Evaluation of the etest method using Mueller-Hinton agar with glucose and methylene blue for determining amphotericin B MICs for 4,936 clinical isolates of Candida speciesM A Pfaller
Department of Pathology, Roy J and Lucille A Carver College of Medicine, Iowa City, Iowa, USA
J Clin Microbiol 42:4977-9. 2004..albicans, 95.1%; C. glabrata, 94.3%; C. krusei, 91.6%; C. parapsilosis, 86.6%; and C. tropicalis, 86.4%. The Etest method using MH-GMB appears to be a useful method for determining amphotericin B susceptibilities of Candida species...
Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing with the 24-hour CLSI BMD method for testing susceptibility of Candida species to fluconazole, posaconazole, and voriconazole by use of epM A Pfaller
Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA
J Clin Microbiol 49:845-50. 2011..These results provide additional data in favor of the harmonization of these two methods...
In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolatesM A Pfaller
Department of Pathology, University of Iowa College of Medicine, Iowa City 52242, USA
Antimicrob Agents Chemother 47:1068-71. 2003..These results provide further evidence for the spectrum and potency of caspofungin activity against a large and geographically diverse collection of clinically important isolates of Candida spp...
Cross-resistance between fluconazole and ravuconazole and the use of fluconazole as a surrogate marker to predict susceptibility and resistance to ravuconazole among 12,796 clinical isolates of Candida sppM A Pfaller
Department of Pathology, Roy J and Lucille A Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA
J Clin Microbiol 42:3137-41. 2004..Fluconazole may serve as a surrogate marker to predict the susceptibility of Candida spp. to ravuconazole...
Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007M A Pfaller
Medical Microbiology Division, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA
J Clin Microbiol 47:3185-90. 2009..The oldest age group (> or = 80 years) had the highest proportion of BSI isolates that were C. glabrata (32%) and the lowest rate of fluconazole resistance (5%)...
In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazoleM A Pfaller
Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA
J Clin Microbiol 43:5425-7. 2005..These results provide further evidence for the spectrum and potency of anidulafungin activity against a large and geographically diverse collection of clinically important isolates of Candida spp...
Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance programM A Pfaller
Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA
J Clin Microbiol 44:3578-82. 2006..C. rugosa should be considered, along with the established pathogens Candida krusei and Candida glabrata, as a species of Candida with reduced susceptibility to the azole antifungal agents...
Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methodsM A Pfaller
Medical Microbiology Division, Department of Pathology, Roy J and Lucille A Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242, USA
J Clin Microbiol 47:3142-6. 2009..The establishment of the WT MIC distribution and ECVs for the azoles and A. fumigatus will be useful in resistance surveillance and is an important step toward the development of clinical breakpoints...
Selection of a surrogate agent (fluconazole or voriconazole) for initial susceptibility testing of posaconazole against Candida spp.: results from a global antifungal surveillance programM A Pfaller
Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA
J Clin Microbiol 46:551-9. 2008..0% M) when results for Candida krusei (not indicated for fluconazole testing) were omitted. Either fluconazole or voriconazole MIC results may serve as surrogate markers to predict the susceptibility of Candida spp. to posaconazole...
Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005M A Pfaller
Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA
J Clin Microbiol 46:515-21. 2008..25 microg/ml). C. krusei is an uncommon but multidrug-resistant fungal pathogen. Among the systemically active antifungal agents, the echinocandins appear to be the most active against this important pathogen...
Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testingM A Pfaller
Department of Pathology, Roy J and Lucille A Carver College of Medicine, University of Iowa College of Medicine, Iowa City, IA 52242, USA
J Clin Microbiol 45:1735-45. 2007..These organisms may pose a future threat to optimal antifungal therapy and emphasize the importance of prompt and accurate species identification...
Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001M A Pfaller
Department of Pathology, Roy J and Lucille A Carver College of Medicine and College of Public Health, University of Iowa, Iowa City, Iowa 52242, USA
J Clin Microbiol 41:1440-6. 2003..Continued surveillance and refinement of broth- and agar-based test methods will help to identify susceptibility trends and improve the laboratory capability for antifungal susceptibility testing...
Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff valuesM A Pfaller
University of Iowa College of Medicine, Iowa City, IA, USA
Diagn Microbiol Infect Dis 73:365-8. 2012..to the echinocandins when using the new (lower) CBPs and ECVs. Further study using defined fks mutant strains of Candida is warranted...
Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic locationM A Pfaller
Department of Pathology, Medicine, Roy J and Lucille A Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242, USA
J Clin Microbiol 41:2176-9. 2003..S. Bureau of the Census). Isolates from pediatric patients were virtually all susceptible to fluconazole, whereas the highest frequency of resistance was observed in isolates from patients 16 to 64 years of age...
In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida sppM A Pfaller
Department of Pathology, University of Iowa College of Medicine, and College of Public Health, Iowa City, Iowa 52242, USA
Antimicrob Agents Chemother 46:1723-7. 2002..krusei. These results provide further evidence for the spectrum and potency of ravuconazole and voriconazole against a large and geographically diverse collection of Candida spp...
Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpointsM A Pfaller
Department of Pathology, 200 Hawkins Drive, University of Iowa, Iowa City, IA 52242 1009, USA
J Clin Microbiol 46:2620-9. 2008..Subsequently, the isolates should be submitted to a reference laboratory that will confirm the results by using a CLSI reference dilution method...
Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida sppM A Pfaller
Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA
J Clin Microbiol 45:3522-8. 2007..9 to 97.4% at the 48-h BMD time point. The VITEK 2 system reliably detected flucytosine and voriconazole resistance among Candida spp. and demonstrated excellent quantitative and qualitative agreement with the reference BMD method...
Comparison of results of fluconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance programM A Pfaller
Department of Pathology, Roy J and Lucille A Carver College of Medicin and College of Public Health, University of Iowa College of Medicine, Iowa City, IA 52242, USA
J Clin Microbiol 42:3607-12. 2004....
Wild-type MIC distributions and epidemiological cutoff values for posaconazole and voriconazole and Candida spp. as determined by 24-hour CLSI broth microdilutionM A Pfaller
Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242 1009, USA
J Clin Microbiol 49:630-7. 2011..The CBP is inadequate in detecting the emergence of voriconazole resistance among most Candida species encountered clinically. The CBPs for voriconazole should be reassessed, with consideration for development of species-specific CBPs...
Evaluation of Etest method for determining fluconazole and voriconazole MICs for 279 clinical isolates of Candida species infrequently isolated from bloodM J Maxwell
Departments of Pathology. Medicine. Epidemiology, University of Iowa College of Medicine and College of Public Health, Iowa City, Iowa 52242, USA
J Clin Microbiol 41:1087-90. 2003..The Etest method using RPMI agar appears to be a useful method for determining fluconazole and voriconazole susceptibilities of uncommon species of Candida...
Stability of Mueller-Hinton agar supplemented with glucose and methylene blue for disk diffusion testing of fluconazole and voriconazoleM A Pfaller
Departments of Pathology, Roy J and Lucille A Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242, USA
J Clin Microbiol 42:1288-9. 2004..Prepared MH-GMB agar plates provide acceptable performance for disk diffusion testing for at least 30 days when stored at 5 degrees C...
In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillanceM A Pfaller
Departments of Pathology, Epidemiology, Roy J and Lucille A Carver College of Medicine and College of Public Health, University of Iowa, Iowa City, Iowa 52242, USA
J Clin Microbiol 44:760-3. 2006..Our prospective sentinel surveillance reveals no evidence of emerging caspofungin resistance among invasive clinical isolates of Candida...
Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida sppM A Pfaller
Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA
J Clin Microbiol 48:52-6. 2010..9%) for C. guilliermondii. These WT MIC distributions and ECVs will be useful in surveillance for emerging reduced echinocandin susceptibility among Candida spp. and for determining the importance of various FKS1 or other mutations...
Further standardization of broth microdilution methodology for in vitro susceptibility testing of caspofungin against Candida species by use of an international collection of more than 3,000 clinical isolatesM A Pfaller
Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA
J Clin Microbiol 42:3117-9. 2004..The MICs for >99% of isolates were </=1 microg/ml, and thus these isolates were differentiated from strains with reduced in vitro and in vivo susceptibilities to caspofungin...
Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida sppS A Messer
Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA
J Clin Microbiol 44:324-6. 2006..Micafungin may prove useful in the treatment of infections due to azole-resistant Candida...
In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole: global survey of 9,359 isolates tested by clinical and laboratory standards institute broth microdilution methodsM A Pfaller
Department of Pathology, Medical Microbiology Division, C606 GH, University of Iowa College of Medicine, Iowa City, IA 52242, USA
J Clin Microbiol 43:3807-10. 2005..In light of the new intravenous formulation of itraconazole these data suggest that this agent remains a viable systemically active antifungal agent...
Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilutionM A Pfaller
JMI Laboratories, North Liberty, Iowa, USA
J Clin Microbiol 50:2040-6. 2012..0) for C. guilliermondii. In the absence of species-specific CBP values, these wild-type (WT) MIC distributions and ECVs will be useful for monitoring the emergence of reduced susceptibility to these well-established antifungal agents...
Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance programM A Pfaller
Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA
J Clin Microbiol 44:3551-6. 2006..5/1.0 microg/ml). C. guilliermondii, a species that exhibits reduced susceptibility to fluconazole, is the sixth most frequently isolated Candida species from this large survey and may be an emerging pathogen in Latin America...
In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillanceM A Pfaller
Medical Microbiology Division, C606 GH, Department of Pathology, Lucille A Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA
J Clin Microbiol 46:150-6. 2008..Our prospective sentinel surveillance reveals no evidence of emerging echinocandin resistance among invasive clinical isolates of Candida spp...
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusionM A Pfaller
Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA
J Clin Microbiol 48:1366-77. 2010..These organisms may pose a future threat to optimal antifungal therapy and underscore the importance of prompt and accurate species identification and antifungal susceptibility testing...
Validation of 24-hour posaconazole and voriconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: application of epidemiological cutoff values to results from a global Candida antifungal surveillance programM A Pfaller
Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA
J Clin Microbiol 49:1274-9. 2011..to these important antifungal agents. The applications of ECVs to this large collection of Candida isolates suggests the potential to develop 24-h species-specific clinical breakpoints for both posaconazole and voriconazole...
In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference M38-A microdilution methods for determining posaconazole MICsM A Pfaller
Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA
Diagn Microbiol Infect Dis 45:241-4. 2003..The Etest method using RPMI agar appears to be a useful method for determining posaconazole susceptibilities of filamentous fungi...
In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from bloodM A Pfaller
Department of Pathology, University of Iowa College of Medicine and College of Public Health, Iowa City, 52242, USA
J Clin Microbiol 41:78-83. 2003..Continued surveillance will be necessary to detect the emergence of these species as more prevalent, resistant pathogens. The new triazoles appear to offer acceptable coverage of uncommon Candida sp. bloodstream infections...
Comparison of the Vitek gram-positive susceptibility 106 card, the MRSA-Screen latex agglutination test, and mecA analysis for detecting oxacillin resistance in a geographically diverse collection of clinical isolates of coagulase-negative staphylococciT Yamazumi
Medical Microbiology Division, Department of Pathology University of Iowa College of Medicine, Iowa City, Iowa, USA
J Clin Microbiol 39:3633-6. 2001..Although the MRSA-Screen test required a slight procedural modification, both commercial methods achieved a sensitivity and specificity at detecting oxacillin resistance in CoNS at a level that was acceptable for clinical laboratory use...
In vitro susceptibility testing of Aspergillus spp.: comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICsJ B Pfaller
Departments of Pathology. Medicine. Epidemiology, University of Iowa College of Medicine and College of Public Health, Iowa City, Iowa 52242, USA
J Clin Microbiol 41:1126-9. 2003..The Etest method using RPMI agar appears to be a useful method for determining the voriconazole and itraconazole susceptibilities of Aspergillus spp...
Evaluation of Etest method for determining voriconazole and amphotericin B MICs for 162 clinical isolates of Cryptococcus neoformansM J Maxwell
Department of Pathology, University of Iowa College of Medicine and College of Public Health, Iowa City, Iowa 52242, USA
J Clin Microbiol 41:97-9. 2003..The Etest method using RPG agar appears to be a useful method for determining the susceptibility of C. neoformans to voriconazole and amphotericin B...
Epidemiology of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in a rural statePhilip M Polgreen
Division of Infectious Diseases, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, 52246, USA
Infect Control Hosp Epidemiol 27:252-6. 2006..CONCLUSIONS: In Iowa, the epidemiology of MRSA differ from those of VRE. MRSA has become established in small rural hospitals. Effective MRSA control strategies may require inclusion of all hospitals in a state or region...
Descriptive epidemiology and case-control study of patients colonized with vancomycin-resistant enterococcus and methicillin-resistant Staphylococcus aureusBryndis Sigurdardottir
Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA
Infect Control Hosp Epidemiol 27:913-9. 2006..aureus colonization or infection. The number of invasive devices to which patients are exposed and, thus, possibly the patients' underlying severity of illness, as well as renal insufficiency, appear to be risk factors for CC/CI...
Identification of Candida nivariensis and Candida bracarensis in a large global collection of Candida glabrata isolates: comparison to the literatureShawn R Lockhart
University of Iowa, Carver College of Medicine, Iowa City, Iowa 52242, USA
J Clin Microbiol 47:1216-7. 2009..Both species were very rare in this collection (0.2% prevalence), despite the number of isolates analyzed and the global distribution of the isolates. We saw no associated antifungal resistance in C. nivariensis...
Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infectionMichael J Klevay
Department of Medicine, University of Iowa, Iowa City, 52242, USA
Diagn Microbiol Infect Dis 64:152-7. 2009..The lack of difference in mortality between species may reflect the overriding importance of host variables and/or a difference in virulence by species: further study is needed to investigate these hypotheses...
Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial managementErik L Munson
Division of Medical Microbiology, Department of Pathology, University of Iowa College of Medicine, Iowa City, Iowa 55242, USA
J Clin Microbiol 41:495-7. 2003..Most therapy interventions occurred at the time of phlebotomy and after notification of Gram stain results by telephone. Release of antimicrobial susceptibility data had the least impact on antimicrobial management...
Emergence of the USA300 strain of methicillin-resistant Staphylococcus aureus in a burn-trauma unitLucy A Wibbenmeyer
Department of Surgery, The University of Iowa Carver College of Medicine, Iowa City, Iowa 52242, USA
J Burn Care Res 29:790-7. 2008..Burn patients may be at risk for numerous abscesses with USA300, because they have open wounds and their immune systems may be compromised...
Epidemiology of invasive candidiasis: a persistent public health problemM A Pfaller
Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA
Clin Microbiol Rev 20:133-63. 2007..Further research to improve diagnostic, preventive, and therapeutic strategies is necessary to reduce the considerable morbidity and mortality associated with IC...
Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteriaM A Pfaller
University of Iowa, Iowa City, United States
Drug Resist Updat 14:164-76. 2011..12 mcg/ml (I), and ≥ 0.25 mcg/ml (R). New, species-specific CBPs for Candida and the echinocandins are more sensitive to detect emerging resistance associated with fks mutations, and better able to predict risk for clinical failure...
Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methodsM A Pfaller
University of Iowa, Iowa City, IA, USA
Drug Resist Updat 13:180-95. 2010..EUCAST CBPs are species-specific, and apply only to C. albicans, C. tropicalis and C. parapsilosis, while CLSI CBPs apply to all species. We reassessed the CLSI CBPs for FLU and Candida in light of recent data...
Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida speciesM A Pfaller
Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, IA 52242 1009, USA
J Clin Microbiol 48:1592-9. 2010..All three test methods showed a high level of agreement and of ability to distinguish fks mutant strains of Candida species from WT strains using each of the echinocandins...
Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogensM A Pfaller
Medical Microbiology Division, Department of Pathology, University of Iowa College of Medicine, Iowa City, Iowa 52242, USA
J Clin Microbiol 47:3797-804. 2009..g., Mucor and Fusarium). Further evaluation of fungal HDAC inhibitor-azole combinations is indicated...
Clinical evaluation of the Sensititre YeastOne colorimetric antifungal panel for antifungal susceptibility testing of the echinocandins anidulafungin, caspofungin, and micafunginM A Pfaller
Department of Pathology, Medical Microbiology Division, University of Iowa College of Medicine, Iowa City, IA 52242, USA
J Clin Microbiol 46:2155-9. 2008..The YeastOne colorimetric method appears to be comparable to the CLSI reference method for testing the susceptibility of Candida spp. to the echinocandins anidulafungin, caspofungin, and micafungin...
Validation of 24-hour fluconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: results from a global Candida antifungal surveillance programM A Pfaller
Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA
J Clin Microbiol 46:3585-90. 2008..4%, with 0.1% VME. Both the MIC and the disk diffusion results obtained for fluconazole after only 24 h of incubation may be used to determine the susceptibilities of Candida spp. to this widely used antifungal agent...
Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida sppM A Pfaller
Medical Microbiology Division, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA
J Clin Microbiol 45:796-802. 2007..The VITEK 2 system reliably detected fluconazole resistance among Candida spp. and demonstrated excellent quantitative and qualitative agreement with the reference BMD method...
Clinical evaluation of a frozen commercially prepared microdilution panel for antifungal susceptibility testing of seven antifungal agents, including the new triazoles posaconazole, ravuconazole, and voriconazoleM A Pfaller
Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA
J Clin Microbiol 40:1694-7. 2002..The overall agreement for each antifungal agent ranged from 96% for ravuconazole to 100% for amphotericin B. The Trek microdilution panel appears to be a viable alternative to frozen microdilution panels prepared in-house...
Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testingM A Pfaller
Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA
J Clin Microbiol 43:5848-59. 2005..quot;..
Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpointsM A Pfaller
Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa College of Medicine, Iowa City, Iowa 52242, USA
J Clin Microbiol 44:819-26. 2006..The corresponding disk test breakpoints are as follows: S, > or = 17 mm; SDD, 14 to 16 mm; and R, < or = 13 mm...
Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatusM A Pfaller
Department of Pathology, College of Medicine, University of Iowa, Iowa City, Iowa 52242, USA
J Clin Microbiol 42:4419-31. 2004
Macrolide use identified as risk factor for macrolide-resistant Streptococcus pneumoniae in a 17-center case-control studyS E Beekmann
Division of Medical Microbiology, Department of Pathology 265 MRC, University of Iowa, Iowa, IA, 52242, USA
Eur J Clin Microbiol Infect Dis 25:335-9. 2006..pneumoniae. Macrolide resistance was associated with use of any antibiotic during the prior 6 weeks, and was most strongly associated with previous macrolide use...
Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002M A Pfaller
Department of Pathology, Roy J and Lucille A Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA
J Clin Microbiol 42:3142-6. 2004..06 microg/ml) and flucytosine (MIC(90), 0.12 microg/ml) and exhibited variable cross-resistance to posaconazole, ravuconazole, and voriconazole...
Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testingM A Pfaller
Department of Pathology, Medical Microbiology Division, C606 GH, University of Iowa College of Medicine, Iowa City, 52242, USA
Clin Microbiol Rev 19:435-47. 2006..S, MIC <or= 8 microg/ml; susceptible-dose dependent (SDD), MIC = 16 to 32 microg/ml; R, MIC >or= 64 microg/ml. The corresponding disk test breakpoints are as follows: S, >or=19 mm; SDD, 15 to 18 mm; R, <or=14 mm...
Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004)M A Pfaller
Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA
J Clin Microbiol 43:2163-7. 2005..We conclude that in vitro resistance to antifungal agents used in the treatment of cryptococcosis remains uncommon among isolates of C. neoformans from five broad geographic regions and has not increased over a 15-year period...
Minimizing the workup of blood culture contaminants: implementation and evaluation of a laboratory-based algorithmS S Richter
Medical Microbiology Division, Department of Pathology, University of Iowa College of Medicine, Iowa City, Iowa 52242, USA
J Clin Microbiol 40:2437-44. 2002..6% of 71 isolates. The laboratory-based algorithm provided an acceptably accurate means for assessing the clinical significance of potential contaminants recovered from blood cultures...
Effects of rapid detection of bloodstream infections on length of hospitalization and hospital chargesS E Beekmann
Division of Medical Microbiology, Department of Pathology, University of Iowa College of Medicine, Iowa City, Iowa 52242, USA
J Clin Microbiol 41:3119-25. 2003..The newest generation of automated continuous-monitoring blood culture systems, which shorten the time required to obtain a positive result, should impact length of hospitalization...
Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibilityM A Pfaller
Department of Pathology, College of Medicine, University of Iowa, Iowa City, IA 52242, USA
J Clin Microbiol 40:3551-7. 2002
Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent casesSandra S Richter
Department of Pathology, University of Iowa Roy J and Lucille A Carver College of Medicine, 200 Hawkins Drive, C606 GH, Iowa City, IA 52242 1009, USA
J Clin Microbiol 43:2155-62. 2005..These results support the use of azoles for empirical therapy of uncomplicated candidal vulvovaginitis. Recurrent episodes are more often caused by non-albicans species, for which azole agents are less likely to be effective...
Variation in the use of procedures to monitor antimicrobial resistance in U.S. hospitalsStephen D Flach
Department of Internal Medicine, Iowa City Veterans Affairs Medical Center, Iowa City, Iowa 52242, USA
Infect Control Hosp Epidemiol 26:31-8. 2005..Antimicrobial resistance is a growing clinical and public health crisis. Experts have recommended measures to monitor antimicrobial resistance; however, little is known regarding their use...
Identification and Susceptibility Profile of Candida fermentati from a worldwide collection of Candida guilliermondii clinical isolatesShawn R Lockhart
University of Iowa, Carver College of Medicine, Iowa City, Iowa 52242, USA
J Clin Microbiol 47:242-4. 2009..With the exception that the MICs of micafungin were significantly lower, the calculated average MICs for C. fermentati were not significantly different from those for C. guilliermondii...
Implementation of strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in U.S. hospitalsMarcia M Ward
Department of Health Management and Policy, University of Iowa, Iowa City, Iowa 52242 1008, USA
Infect Control Hosp Epidemiol 26:21-30. 2005....
Methicillin-resistant Staphylococcus aureus (MRSA) strain ST398 is present in midwestern U.S. swine and swine workersTara C Smith
Department of Epidemiology, University of Iowa College of Public Health, Iowa City, IA, USA
PLoS ONE 4:e4258. 2009..However, no studies to date have investigated carriage of MRSA among swine and swine farmers in the United States (U.S.)...
Fluoroquinolone resistance in Streptococcus pyogenesSandra S Richter
Department of Pathology, University of Iowa Healthcare, Iowa City, Iowa 52242, USA
Clin Infect Dis 36:380-3. 2003..This is the second report of a clinical isolate of S. pyogenes with high-level fluoroquinolone resistance...
Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance ProgramMichael A Pfaller
Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA
Diagn Microbiol Infect Dis 65:27-34. 2009....
Prenatal testing for infectious diseaseJanet I Andrews
Division of Maternal Fetal Medicine, Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, SW44 14 GH, 200 Hawkins Drive, Iowa City, IA 52242 1080, USA
Clin Lab Med 23:295-315, viii. 2003..Recent advances in diagnostic testing (such as avidity testing) is included. Testing issues focus on the diagnosis of maternal and fetal infection...
Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance ProgramMichael A Pfaller
Medical Microbiology Division, Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA
Diagn Microbiol Infect Dis 67:162-71. 2010..glabrata. Prompt species identification and fluconazole susceptibility testing are necessary to optimize therapy for invasive candidiasis...
